Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines.

MLA

Jennings, Barbara A., et al. “Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines.” PLoS ONE, vol. 10, no. 4, Apr. 2015, p. 1. EBSCOhost, https://doi.org/10.1371/journal.pone.0124893.

APA

Jennings, B. A., Loke, Y. K., Skinner, J., Keane, M., Chu, G. S., Turner, R., Epurescu, D., Barrett, A., & Willis, G. (2015). Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines. PLoS ONE, 10(4), 1. https://doi.org/10.1371/journal.pone.0124893

Chicago

Jennings, Barbara A., Yoon K. Loke, Jane Skinner, Melanie Keane, Gavin S. Chu, Richard Turner, Daniel Epurescu, Ann Barrett, and Gavin Willis. 2015. “Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines.” PLoS ONE 10 (4): 1. doi:10.1371/journal.pone.0124893.